ATE378328T1 - Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung - Google Patents

Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Info

Publication number
ATE378328T1
ATE378328T1 AT02712114T AT02712114T ATE378328T1 AT E378328 T1 ATE378328 T1 AT E378328T1 AT 02712114 T AT02712114 T AT 02712114T AT 02712114 T AT02712114 T AT 02712114T AT E378328 T1 ATE378328 T1 AT E378328T1
Authority
AT
Austria
Prior art keywords
pyrrolo
prodrugs
indole
tumor treatment
quinoline derivatives
Prior art date
Application number
AT02712114T
Other languages
English (en)
Inventor
Mark Searcey
L Patterson
Original Assignee
Univ London Pharmacy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Pharmacy filed Critical Univ London Pharmacy
Application granted granted Critical
Publication of ATE378328T1 publication Critical patent/ATE378328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02712114T 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung ATE378328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01301636 2001-02-22

Publications (1)

Publication Number Publication Date
ATE378328T1 true ATE378328T1 (de) 2007-11-15

Family

ID=8181737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02712114T ATE378328T1 (de) 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Country Status (7)

Country Link
US (1) US7626026B2 (de)
EP (1) EP1409480B1 (de)
JP (1) JP2004529887A (de)
AT (1) ATE378328T1 (de)
DE (1) DE60223544T2 (de)
ES (1) ES2299560T3 (de)
WO (1) WO2002068412A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408960B1 (de) * 2001-02-22 2006-05-31 School Of Pharmacy, University Of London Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
GB0505644D0 (en) 2005-03-18 2005-04-27 Univ London Pharmacy Analogues of the azinomycins as anti-tumour agents and as prodrugs
CA2674831A1 (en) 2006-12-22 2008-11-13 Schering Corporation 5,6-ring annulated indole derivatives and methods of use thereof
US8546420B2 (en) * 2006-12-22 2013-10-01 Merck Sharp & Dohme Corp. 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
US8557848B2 (en) * 2006-12-22 2013-10-15 Merck Sharp & Dohme Corp. 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
WO2009032125A1 (en) 2007-08-29 2009-03-12 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
KR20100049667A (ko) 2007-08-29 2010-05-12 쉐링 코포레이션 바이러스 감염 치료용 2,3-치환된 인돌 유도체
BRPI0815811A2 (pt) 2007-08-29 2015-02-18 Schering Corp Derivados de indol substituído e métodos de uso dos mesmos
WO2009064852A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-aminosulfonyl substituted indole derivatives and methods of use thereof
CA2705586A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
AR072088A1 (es) 2008-06-13 2010-08-04 Schering Corp Derivados de indol triciclicos y sus metodos de uso
ES2647317T3 (es) 2008-11-03 2017-12-20 Syntarga B.V. Análogos de CC-1065 y sus conjugados
EP3108886B1 (de) 2010-04-21 2020-06-17 Syntarga B.V. Konjugate von cc-1065 analogen und bifunktionelle linker
US8496218B2 (en) * 2011-06-08 2013-07-30 Alcon Research, Ltd. Display monitor guide
DK3092010T3 (en) 2014-01-10 2018-08-27 Synthon Biopharmaceuticals Bv Process for purification of Cys-linked antibody-drug conjugates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413132A (en) 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
GB2190724B (en) 1986-04-16 1990-08-08 Courtaulds Plc Composite element
FI85403C (fi) 1989-12-22 1992-04-10 Neste Oy Foerfarande foer framstaellning av en plastkompositbalk eller -pelare med staolfoerstaerkningen.
ES2149768T3 (es) 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
FR2700805B1 (fr) 1993-01-27 1995-04-07 Ind Entreprise Procédé de renforcement d'une poutre détériorée, et poutre ainsi obtenue.
US5448869A (en) 1994-02-17 1995-09-12 Marvin Lumber And Cedar Co. Composite framing member and window or door assembly incorporating a composite framing member
US5720143A (en) 1994-03-01 1998-02-24 The United States Of America As Represented By The Secretary Of Agriculture Localized notch reinforcement for wooden beams
US5501054A (en) 1994-03-01 1996-03-26 The United States Of America As Represented By The Secretary Of Agriculture Bolted wood connections
US5679432A (en) 1994-05-09 1997-10-21 Benchmark Foam, Inc. Multi-layer laminate structure
US5688426A (en) 1995-06-07 1997-11-18 The Boeing Company Hybrid metal webbed composite beam
US5657595A (en) 1995-06-29 1997-08-19 Hexcel-Fyfe Co., L.L.C. Fabric reinforced beam and column connections
GB9519490D0 (en) 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
JP2000506168A (ja) 1996-03-08 2000-05-23 ザ スクリップス リサーチ インスティテュート Ｃｃ―１０６５及びデュオカマイシンのｍｃｂｉ類似体
US5843937A (en) 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
US6060608A (en) 1996-05-31 2000-05-09 The Scripps Research Institute Analogs of CC-1065 and the duocarmycins
US5794402A (en) 1996-09-30 1998-08-18 Martin Marietta Materials, Inc. Modular polymer matrix composite support structure and methods of constructing same
AU754083B2 (en) * 1997-05-22 2002-11-07 Scripps Research Institute, The Analogs of duocarmycin and CC-1065
ES2226332T3 (es) 1998-02-06 2005-03-16 De Montfort University Profarmacos activados mediante hidroxilacion.

Also Published As

Publication number Publication date
DE60223544D1 (de) 2007-12-27
ES2299560T3 (es) 2008-06-01
US20040157873A1 (en) 2004-08-12
DE60223544T2 (de) 2008-09-25
JP2004529887A (ja) 2004-09-30
EP1409480A1 (de) 2004-04-21
WO2002068412A1 (en) 2002-09-06
US7626026B2 (en) 2009-12-01
EP1409480B1 (de) 2007-11-14

Similar Documents

Publication Publication Date Title
ATE378328T1 (de) Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung
ATE327750T1 (de) Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
DE60220057D1 (de) Indoline und tetrahydro-chinoline als prodrugs zur tumorbehandlung
PT2420234E (pt) 1h-benzimidazole-4-carboxamidas substituídas com um carbono quaternário na posição 2 como inibidores de parp para uso no tratamento do cancro
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
EP4272748A3 (de) Antisense-oligonukleotide zur induzierung von exon-skipping und verfahren zur verwendung davon
SG164368A1 (en) Treatment of cancer
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
WO2004062613A3 (en) Hiv integrase inhibitors
MX2009004888A (es) Inhibidores del virus de la hepatitis c.
NZ580226A (en) Dimer compounds as inhibitors of iap
MX2009006864A (es) Inhibidores novedosos de c jun-n-terminal cinasas.
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
WO2010003475A3 (de) Neue pyrrolidinderivate als metap-2 inhibitoren
MX2007003470A (es) Compuestos de carbonilo los cuales pueden utilizarse como inhibidores del factor de coagulacion xa.
HK1104290A1 (en) Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
MX2007006610A (es) Metodo para simplificar acidos nucleicos microbianos por modificacion quimica de citosinas.
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
TW200745074A (en) New pharmaceutical compounds
MY152061A (en) Pyrrolopyrimidinecarboxamides
MX2007006090A (es) 2-metilen-19-nor-(20r)-1a-hidroxi-bishomopregnacalciferol.
WO2006124996A3 (en) Inhibitors of polo-like kinase-1
WO2008152306A3 (fr) Nouveaux substrats de peptidase
SI1845780T1 (sl) Uporaba derivatov metilfenidata

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties